clopidogrel and Bright Disease

clopidogrel has been researched along with Bright Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Daig, U; Eisenberg, R; Gaedeke, J; Krämer, S; Liefeldt, L; Neumayer, HH; Peters, H; Westenfeld, R	1

Other Studies

1 other study(ies) available for clopidogrel and Bright Disease

Article	Year
Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritis. Kidney international, 2004, Volume: 65, Issue:6 Topics: Animals; Blood Platelets; Clopidogrel; Glomerulonephritis; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thy-1 Antigens; Ticlopidine; Transforming Growth Factor beta; Transforming Growth Factor beta1	2004

Article

Year

Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritis.

Kidney international, 2004, Volume: 65, Issue:6

Topics: Animals; Blood Platelets; Clopidogrel; Glomerulonephritis; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thy-1 Antigens; Ticlopidine; Transforming Growth Factor beta; Transforming Growth Factor beta1

2004